Leading Indian pharma company Glenmark Pharmaceuticals has announced an interim dividend of Rs 2.50 per equity share of face value Rs 1 each for the financial year 2025–26. The total payout under this declaration will amount to Rs 705.50 million, according to the company’s stock exchange filing.
Glenmark Pharmaceutical: Interim dividend record date
The record date has been fixed for Friday, October 3, 2025, meaning anyone holding the stock on that day is entitled to the interim dividend. Payment will follow within 30 days of declaration, as per the company’s formal commitment. All of this was locked in right after the company’s annual general meeting on September 26, 2025, which turned out to be more than just routine housekeeping.
Glenmark Pharmaceuticals share price trends
On the day of the AGM, the company’s shares closed at Rs 1970.30, down 2.99% from the previous session’s Rs 2031.00. The scrip has seen volatility in recent weeks, losing 7.53% in the past two weeks. Still, the longer-term picture remains more favourable, up 0.92% in the past month, 13.79% over three months, and 17.49% in the past year.
Over a three-year horizon, however, the stock has surged an extraordinary 435.48%, delivering returns that place it among the strongest performers in the sector. Its 52-week high stands at Rs 2286.15, while the 52-week low is at Rs 1274.70.
On October 1, 2025, Glenmark Pharma share price closed in green up 0.27 per cent at Rs 1,958, on NSE.
With a market capitalization of Rs 55,602.03 crore, the company is part of the BSE 500 index, cementing its role among large listed entities.
This announcement came amid the muted financial performance of the pharma company in Q1FY26. Glenmark Pharmaceuticals posted a sharp 86% year-on-year decline in consolidated net profit for the first quarter of FY26, dropping to Rs 46.87 crore from Rs 340.27 crore in the same quarter of the previous year. On a quarter-on-quarter basis, however, profit jumped significantly from Rs 4.65 crore reported in Q4FY25.